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Abstract: Computational Biology has increasingly become an important tool for 
biomedical and translational research. In particular, when generating novel 
hypothesis despite fundamental uncertainties in data and mechanistic 
understanding of biological processes underpinning diseases. While in the 
present book, we have reviewed the necessary background and existing novel 
methodologies that set the basis for dealing with uncertainty, there are still 
many “grey”, or less well-defined, areas of investigations offering  both 
challenges and opportunities. This final chapter in the book provides some 
reflections on those areas, namely: (1) the need for novel robust mathematical 
and statistical methodologies to generate hypothesis under uncertainty; (2) the 
challenge of aligning those methodologies in a context that requires larger 
computational resources; (3) the accessibility of modeling tools for less 
mathematical literate researchers; and (4) the integration of models with –omics 
data and its application in clinical environments.  
 





There are two underlying rationales that motivate the chapters in this book. The 
first, is the usefulness and necessity of mechanistic mathematical and 
computational modeling in biomedical research. The usefulness has been widely 
shown in several chapters (see for instance Chapter Stochastic modeling and 
simulation methods for biological processes: overview by Lejon and Samaey and 
Chapter Bayesian model selection methods and their application to biological ODE 
systems by Hug et al.) and (for instance) from classical groundbreaking works in 
neuron modeling (such as (Hodgkin & Huxley, 1952). The necessity of 
mechanistic modeling originates essentially from the limitations w.r.t 
mechanistic understanding when solely using classical statistical analysis in the 
analysis of complex systems (Zhu et al, 2008; Gomez-Ramirez & Sanz, 2013; 
Petersson et al, 1999).  
The second rationale is that mechanistic modeling in biology needs to address 
uncertainty in order to generate testable hypothesis. For instance in biology 
when a transcript is profiled - either by PCR, array or RNA-seq – there are 
several sources of variability to consider: technical, from the experimental 
procedure use, and biological, that is for instance when the same type of cell may 
react in different ways to the same perturbation. At the cell level, one 
explanation for observed transcriptomics biological variation is that the 
regulation is driven at several and different layers (e.g. genetic and epigenetic 
regulation), but large parts of these regulatory mechanisms are still only in part 
possible to decipher (Luco et al, 2010; Bock, 2012; Heyn et al, 2012; Jones and 
Lian, 2009). Furthermore, the profiles of those “other regulatory layers” are in 
most cases not available during modeling. A second explanation for uncertainty 
is the stochastic nature of some biological processes as shown in intra-cellular 
chemical reactions, gene expression (Magklara and Lomvardas, 2013) and 
pharmacokinetics (Donnet and Samson, 2013) among others. In both 
explanations, we need to clearly face uncertainty during the modeling, in the 
parameters of the model and in the biological processes when investigating model 
behaviors. 
While the first chapter by Geris and Gomez-Cabrero provides an overview, we 
find it useful to close the book with a chapter that summarizes major existing 
challenges and opportunities. We have identified four challenges that will be 
briefly discussed in the different sections of this Chapter. First, (1) there is a 
need for methodological development, (2) linking modeling and high-
performance computing, (3) strengthen the accessibility of modeling tools 
targeting non-specialists and, (4) integrating omics and modeling tools for the 
benefit of personalized medicine.  Additional challenges for the future of 
computational biomedicine, especially with respect to the clinical dimension, can 
be found in the Digital Patient Roadmap1.   
 
The need for methodological development. 
In the last decade, we have observed a shift in biological modeling analysis. In 
initial attempts, mechanistic ordinary differential equation (ODE) models were 
generated by defining a set of equations, and investigators manually fine-tuned 
the parameters. The manual fine-tuning was conducted by exploring the 
parameter space “in the quest” of finding those parameters that agreed with 
experimental observed behavior (we will denote them by “good quality 
parameter sets”). Eventually, the manual search was made automatic by 
designing the fine-tuning problem as an optimization problem as shown in 
Chapter Parameter Estimation and the Associated Optimization Problem by 
Salmuelson et al. Furthermore, with the growth of computational resources the 
parameter space of larger models became intractable using theoretical analysis, 
it became clear that investigations of either exploring the surrounding areas of 
good quality parameter sets (see Chapters Sloppiness and the geometry of 
parameter space by Mannakee et al. and Chapter Sensitivity analysis by design of 
experiments by Van Schepdael et al.) or by exploring the set of “good quality 
parameter sets” (Chapter Neuroswarm: a methodology to explore the constraints 
that function imposes on simulation parameters in large-scale networks of 
biological neurons by Gomez-Cabrero et al.  and Chapter Prediction uncertainty 
estimation despite unidentifiability: an overview of recent developments by 
Cedersund) became important. We consider that those types of methodologies 
are necessary and they are an active research field in computational biology, 
however it still requires a coordinated effort to generate a solid foundation for 
further development. We consider two major requirements: 
 
(1) Rigorous definitions. In order to develop useful methodologies and tools 
we need to provide a robust answer to the following question: what is a useful 
output from the analysis under uncertainty of a biological theoretical model? 
(QUES). In Chapter Neuroswarm: a methodology to explore the constraints that 
function imposes on simulation parameters in large-scale networks of biological 
                                                        
1 http://www.digital-patient.net/files/DP-Roadmap_FINAL_N.pdf  
neurons by Gomez-Cabrero et al. the answer proposed is (briefly) first the 
grouping and secondly group characterization of good quality parameter sets. The 
idea is that by exploring the “good quality parameter set” space it is possible to 
find competing hypothesis (from the groups of “good quality parameter sets”) 
that could be tested at the laboratory. However, given the exploratory nature of 
the proposed methodology (that does not investigate all possible “good quality 
parameter sets” but a sample of them by an optimization methodology) the 
robustness of the competing hypothesis is not rigorously ensured. Chapter 
Prediction uncertainty estimation despite unidentifiability: an overview of recent 
developments by Cedersund answers that the fundamental outputs are the set of 
predictions that can be then tested back in the laboratory. Furthermore Chapter 
Prediction uncertainty estimation despite unidentifiability: an overview of recent 
developments by Cedersund provides an initial classification of predictions: core 
predictions (well-determined predictions that allow to test the quality of the 
model) and suggestions (poorly determined predictions that may provide 
specific insights that can be tested in order to improve the overall quality 
model). Both results and proposals shown in Chapters Sloppiness and the 
geometry of parameter space, Neuroswarm: a methodology to explore the 
constraints that function imposes on simulation parameters in large-scale 
networks of biological neurons by Gomez-Cabrero et al. and Prediction 
uncertainty estimation despite unidentifiability: an overview of recent 
developments by Cedersund represent part of the initial efforts generated to 
provide a formal answer to QUES; however we consider it necessary to develop 
further these efforts and work on generating a consensus and robust formulation 
for answering QUES. Relevant material on the topic can be found in (Gomez-
Cabrero et al, 2011; Kuepfer et al, 2007; Van Riel, 2006; Cedersund, 2012; 
Cedersund and Stralfors, 2009; Cedersund and Roll, 2009).  
 
(2) Development of software tools that implement such methodologies 
so they may become a standard. The shift from manual search to automatic 
search started during last decades of 20th century and actively continued during 
first decade of 21st century. Several teams worked on those ideas and several 
tools were developed at the same time; some of those tools aimed for specific 
areas such as Neuroscience (Neurofitter, (Van Geit et al, 2007)) while some other 
tools were more generic such as COPASI (Hoops et al, 2006). Many of those tools 
are still available (and there are active research groups continuously updating 
them) see Chapter Parameter Estimation and the Associated Optimization 
Problem by Samuelson et al. for further detail. On one hand, the generation of 
that many tools raised the awareness and use of those new methodologies; on 
the other hand it was clear that the wheel was reinvented many times. When 
considering the generation of hypothesis under uncertainty we may argue to be 
at the beginning of user-friendly method development. Yet no tool is able to 
perform automatically the analysis presented in Chapter Neuroswarm: a 
methodology to explore the constraints that function imposes on simulation 
parameters in large-scale networks of biological neurons by Gomez-Cabrero et al. 
or  Chapter Prediction uncertainty estimation despite unidentifiability: an 
overview of recent developments by Cedersund; in those cases customized coding 
solutions were generated. We consider it necessary to generate  user-friendly 
solutions able to perform automatically (or under human supervision) those 
analyses. However we also believe it is necessary to generate coordinated 
working groups to avoid the generation of similar tools simultaneously.  
A final complementary development to those methodologies is the generation of 
novel methodologies and (user-friendly) tools allowing automatic simplification 
and reduction of models as shown in Chapter Modeling and model simplification 
to facilitate biological insights and predictions by Eriksson et al., Chapter Interval 
methods by Tucker or through Global Sensitivity Analysis (Rand, 2008; Kent et al, 
2013; Sumner et al, 2012).  
 
Integration of computational modeling with High-Performance Computing 
techniques. 
Computational resources have been both the key and bottleneck for 
computational modeling analysis. The automatic search for “good quality 
parameter sets” depended on the availability of machines able to run hundreds 
or thousands of simulations in brief periods of time. This was possible through 
medium sized (20+ cores) to large sized (named supercomputers such as Mare 
Nostrum in the Barcelona Supercomputing Center (www.bsc.es, Spain) or SNIC 
solutions (www.snic.vr.se, Sweden) machines; the former was mainly affordable 
by computational-oriented groups able to invest funding in the resource while 
the latter were available through national programs that provided (and still 
provide) a number of hours-per-month upon request. The first computational 
biology analysis competed for such computational resources with theoretical 
physics or computational chemistry (among many others) simulations, but at 
that time the required resources were minor compared to the rest of research 
areas. Over the years, and with both the development of automatic fine-tuning 
tools and larger models, the computational requirements grew and 
computational biology is starting to compete at a similar scale of requirements 
than the other research domains. The present and coming future shows that the 
demand of computational requirements are still to grow for several reasons, 
among them: (i) possible increased size of the models, (ii) increased amount of 
data to be considered (see later the omics’ section for further details) and (iii) an 
increased amount of users (see for instance the development of novel 
conferences such as HiCOMB, High Performance Computational Biology from 
2002 until nowadays). For this reason the long-term resources are to be planned 
carefully in order to correctly asses the future needs of Biological and Medical 
Sciences2. We consider the following three aspects to be of major relevance: 
(1) High-Performance Computing (HPC) infrastructures. There is a 
general trend to avoid buying small-medium computational resources by every 
group and invest better into large-scale resources or cloud-based solutions; see 
for instance the action plan for the Digital Agenda for Europe3. Small-medium 
sized solutions tend to be expensive and, in many cases, sub-optimally used. 
While cloud-based solutions, if prizes are competitive, may provide a cheaper 
solution that will optimally reflect the needs and uses of different research 
groups in real-time. Furthermore, as pointed out by Peter V Coveney4, it is 
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necessary to optimize the interoperability across large infrastructures and it is 
necessary to harmonize mechanisms such as access, advance reservation and 
urgent computing among others.  
(2) Parallelization. Both simulation and fine-tuning benefit from 
parallelization, that is the possibility to run a process as separate parallel batches 
therefore reducing the amount of time by using several CPUs simultaneously. 
Both optimization algorithms and methodologies to integrate Partial Differential 
Equations benefit from better and robust parallelizable algorithms. Interestingly, 
in the area of eScience (“the application of computer technology to the 
undertaking of modern scientific investigation, including the preparation, 
experimentation, data collection, results dissemination, and long-term storage and 
accessibility of all materials generated through the scientific process”, Shannon 
Bohle5) there is an effort to import to computational biology those methods 
already developed for other areas where large-scale modeling is actively used 
(such as Weather Forecast modeling). Among those efforts there is the Swedish 
e-Science Research Center (http://www.e-science.se). 
(3) Scalability. Both for computational resources and parallelization need to 
consider optimal scalability of the solutions developed, given that the number of 
users and computational requirements is expected to grow over time (Finak et 
al, 2014; Gupta et al, 2014).  
 
To widen the use and applicability of modeling as a tool for non-specialists. 
Most of the chapters of this book have been written by statisticians, 
mathematicians, and engineers with a strong mathematical background. This 
may represent the background requirements for method development in 
computational biology, however it does not represent the requirements for using 
computational biology. Fortunately, in the last twenty numerous biologists have 
been exposed to the necessary background to develop and analyze their own 
models. We consider that to make the use of modeling in biomedicine it is 
important to make the necessary knowledge and tools as accessible as possible; 
on this direction we consider that following points are important. 
(1) The necessary theoretical background. When biologists decide to 
design a model of their system under study, it is necessary for them to learn the 
basics of mathematical modeling. General and specific knowledge of modeling 
will be required depending on the system to investigate. The amounts of material 
(specially books) addressing this knowledge have been growing in both quantity 
and user-friendliness. Additionally, courses (such as Computational Biology in 
Cold Spring Harbor, directed by Professor Gregory Smith6) are becoming more 
common. We consider that it is necessary to continue this trend, but also that (i) 
courses where biological-strong and mathematical-strong participants are both 
enlisted are to be prioritized, because it allows exchanging of views and goals 
and creates a richer learning environment (Cascante et al, 2014); and (ii) the 
development of on-line courses addressing this topic needs to receive attention, 
so students may have introductory sessions without the need to wait for face-2-
face courses.   
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(2) Software environments. We consider it necessary to enhance the user-
friendliness of existing (and novel tools) in order to enlist researchers in the use 
of modeling. Existing tools have certainly shown an increase in accessibility and 
friendliness, but any researcher with no experience will still need to invest large 
amounts of time to get confident with them. In PhD programs were modeling 
may be a side project to investigate experimental results this situation may end 
in not considering modeling as a research tool. We consider that our aim must be 
to make “computational modeling” another accessible tool in the biologist tool-
box, therefore improving user-friendliness is necessary. An example of 
generating a simulation environment for medical researchers is (Huertas-
Miguelanez et al, 2014), which is part of the results from the European Project 
Synergy-COPD (Gomez-Cabrero et al, 2014). 
(3) Syllabus implementation. When a clinician or a biologist may interact 
with modelers or discover a model of interest, existing syllabus usually do not 
provide the necessary background to understand them. We consider that 
initiatives such as Erasmus BioHealth Computing Program (Cascante et al, 2014) 
and Medical Research Masters are initiatives of value where future biological and 
medical researchers are set to interact with modelers and computational 
biologists. This approaches enhances the visibility of modeling in biology and 
biomedicine.  
 
Forming stronger ties between Omics Data and Computational Biology. 
Following the Human Genome Project, array-based and Next-Generation 
Sequencing-based technologies have pushed transcriptomics analysis to novel 
boundaries (Metzker, 2010; Almomani et al, 2011). SNP profiling of thousands of 
individuals have allowed the identification of genetic risk factors for many 
diseases such as Multiple Sclerosis (Sawcer et al, 2011) or Rheumatoid Arthritis 
(Raychaudhuri et al, 2012), however the use of such information in 
Computational Models is limited to say the least. A very important open question 
is then: how do we integrate and omics-based knowledge into modeling?  
While omics-data is used in the generation of predictive models (such as patient 
classification or risk prediction) and integrative approaches are being 
continuously developed to improve such models (Anderson and Quarante, 2008; 
Chan and Loscalzo, 2012; Joyce and Palsson, 2006; Ramsey et al, 2010; Voilloslad 
and Baranzini, 2012) what we here refer to  is the use of omics data in the 
analysis of biological systems through mechanistic models.  Eventually those 
integrated mechanistic models may provide in the future relevant information to 
be included in better prediction models making use of simulation outputs.     
However, at the present time we focus on the challenge of creating models that 
address the individual (personalized modeling). Lets consider for instance the 
development of a immune system model of Multiple Sclerosis Progression such 
as the one presented in (Velez de Mendizabal et al, 2011). If we gather 
information of DNA Methylation profiling and/or SNP genotype for a given 
individual, the challenge is now how we implement such information so the 
model is not anymore a generic model but individual specific. There exist several 
attempts on this direction as those shown in Synergy-COPD (Gomez-Cabrero et 
al, 2014) and CombiMS,  in the context of Systems Medicine and the Virtual 
Physiological Human. In order for omics data to be routinely used in 
computational biomedicine and, later on, in a clinical setting, a number of 
requirements need to be fulfilled, as recently identified by (Viceconti et al. 2014).  
These include (1) the ability to work with sensitive data, (2) to work with 
complex and heterogeneous data (including non-textual information), (3) to 
work with a distributed data management under security and performance 
constraints, (4) to define methods allowing for the integration of bioinformatics 
and systems biology information with clinical observations on various length 
scales, and finally (5) to define tools able to define the ‘physiological envelope’ of 
a patient (ref white paper). 
 
Conclusions. 
We find that Computational Biology is a crucial tool for biology and biomedicine, 
but to enhance its practical applicability there is an urgent need to address the 
uncertainty commonly observed in biological systems to ensure the uptake in 
the biological and clinical communities. The present chapter reviews the needs 
and challenges in computational biology, that are important to consider in the 
nearby development of the field. We summarize those needs in three major 
aspects:  
1. Robust definitions for the generation of useful predictions,  
2. Development of novel and optimization of existing HPC resources that 
address the state-of-the-art computational needs. 
3. Development of user-friendly analysis tools and easily accessible 
computing resources, 
4. Development of models and tools that incorporate information on the 
different omics widely profiled nowadays. 
We hope that the reading of this book may motivate young and senior 
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